SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-024738
Filing Date
2024-02-16
Accepted
2024-02-16 09:02:26
Documents
20
Period of Report
2024-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246503d1_8k.htm   iXBRL 8-K 38593
2 EXHIBIT 4.1 tm246503d1_ex4-1.htm EX-4.1 91629
3 EXHIBIT 4.2 tm246503d1_ex4-2.htm EX-4.2 91593
4 EXHIBIT 10.1 tm246503d1_ex10-1.htm EX-10.1 61338
5 EXHIBIT 10.2 tm246503d1_ex10-2.htm EX-10.2 11023
6 EXHIBIT 99.1 tm246503d1_ex99-1.htm EX-99.1 34979
10 GRAPHIC tm246503d1_ex99-1img001.jpg GRAPHIC 5830
  Complete submission text file 0001104659-24-024738.txt   592228

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA hepa-20240215.xsd EX-101.SCH 3009
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20240215_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20240215_pre.xml EX-101.PRE 22355
22 EXTRACTED XBRL INSTANCE DOCUMENT tm246503d1_8k_htm.xml XML 3598
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 24645910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)